"Nucynta is getting rejected by Dr.s"
Nucynta is not being rejected by doctors, I was recently prescribed it over percocet for my herniated discs pain and I know two other guys who just got on it, seems it's gaining traction if anything. I think a strong sell may be better suited when Depo is in the $30 range, unless sales continue higher, as they have been.
"BUT we do know that PFe and AMGN signed NDA's with MDVN"
Do we know that? Reuters reported that (potential rumor) but has MDVN or anyone confirmed it, no.
I hope they have but I would like confirmation that there are other bidders.
Args is a very interesting company, if what they are doing works out well it should hit the highs in a big way.
As for Exel, I have held it in the past with spikes of $7.00 ( in premarket or, extended trading) and was not a seller then, I do anticipate much higher pps going forward, and potentially a buyout.
Medical device companies are anticipated to out perform the general health sector, let Trov be one of them. I kinda like the $12.00 target myself, it's a good start anyway!
Sentiment: Strong Buy
"lol interesting that you actually look at yahoo target,"
It's pretty hard to miss it, it's on the front page of the Exel board under "Ask"
"Is this bill expected to impact Nucynta prescription growth?"
I doubt it, currently in California opioids are controlled more cautiously. When I got my prescription it was written up in the normal way and the pharmacy would not accept it, a call to the doctor and the prescription was written up on a different pad. I do not think legitimate use will be affected at all. One problem I did encounter, I received a prescription for the Nucynta pills but they did a dna test for the sustained release, the doctor said something about determining if I was a fast metabolizer or not as to being a candidate? I am now fighting the insurance company who do not want to cover the cost of that test and question the need for it. I may be forced to pay the $1500, the prescription under my insurance was $25.00 I would have been quite happy with the regular pills, (herniated discs)
"once investors feel like the management turmoil is over, the pps will rebound."
I think you are seeing a little of this in AH, I believe the presentation has reassured the astute on Wall Street that the new CEO may actually be a positive for the company. Remember, the drop in pps was predicated on the instability of management, not the product line. If Trov is seen to be in good hands then the reason for the discount is itself discounted.
We will see tomorrow, Good Luck.
I couldn't find it, when was the article published and do you have the headlines, all I could find were out of date. Thanks
"Bagdad Bob tie clips, cuff links, and a full line of accessories...
Bagdad Bob pipes, papers, and roach clips - after all, it's SF....
Bagdad Bob blow-up dolls, sex gear, and full a line of non-carcinogenic body lubricants.."
Any Mail order options?
"So is the problem price or is it a problem with the company ?
I don't think there is a problem at all, but as translationhell alluded too, it is too early. Once we have European approval and some sales figures then potential buyers will have data they can use to assess Exel. I'm looking to the positive, I think sales may be better than expected and pipeline goes from pipe-dream to reality. I have potential suitors in mind, Asco may shed more light on Exel's potential. Talk in biotech circles is to expect a lot of M&A in the sector, why not Exel.
Sentiment: Strong Buy
Looks like he has unleashed a barrage of his spam now, so many ID's so little IQ.
Last time this guy got out of hand was when the price of MDVN was on the rise, I don't know if he thinks he can kill this board by spamming but the last time it did seem to drive a lot of people away.